HOLMES SCOTT A (Chief Financial Officer) sold 1.4% of their position (2.35K shares) of KERYX BIOPHARMACEUTICALS INC on the open market
Open‑market sale worth $9.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/31/2018ACC: 0001114220-18-000085
Officer· Chief Financial Officer
Since Jul 2018
-2.35K
Net shares
Net seller
$9.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.35K
Price / share
$3.86
Trade value
$9.09K
% of position
1.4%
7/30/2018
168.90K→166.55K
Total
Net shares
−2.35K
Net value
-$9.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2018 | S · Sale | −2.35K | $3.86 | $9.09K | 1.4% | 168.90K | 166.55K |
| Total | −2.35K | -$9.09K | ||||||
Derivative Transactions0
No derivative transactions reported